Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell

Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κB pathway in human colon cancer cell

Jiachi Ma,1 Xiaowen Sun,2 Tiankang Guo,1 He Su,1 Quan Chen,1 Zhenqiang Gong,3 Jianbo Qi,3 Xiaodan Zhao3 1Department of General Surgery, Gansu Provincial People’s Hospital, LanZhou, 2Department of Dermatology, The First Hospital of Tianshui, Tianshui, 3Ningxia Medical University Graduate Sc...

Full description

Bibliographic Details
Main Authors:	Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, Qi J, Zhao X
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-10-01
Series:	Cancer Management and Research
Subjects:	Interleukin receptor antagonist Hepatocyte Growth Factor Metastasis Angiogenesis Colon cancer
Online Access:	https://www.dovepress.com/interleukin-1-receptor-antagonist-inhibits-angiogenesis-via-blockage-i-peer-reviewed-article-CMAR

Similar Items

Content of C-reactive protein, interleukin-1, interleukin-6 and interleukin-1 receptor antagonist in the blood of patients with early osteoarthrosis of the knee joints
by: M S Svetlova, et al.
Published: (2009-06-01)

Evaluation of the Interleukin-1 Receptor Antagonist and Immunoregulatory Interleukin-10 in the Middle Ear in Chronic Otitis Media With Effusion in Children With and Without Atopy
by: Beata Zielnik-Jurkiewicz, et al.
Published: (2016-06-01)

Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer
by: Razelle Kurzrock, et al.
Published: (2019-03-01)

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
by: Yu-Ching Fan, et al.
Published: (2020-12-01)

Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
by: Queenie Hui, et al.
Published: (2017-08-01)

Optimization of the composition of a nasal medicine with interleukin-1 antagonist β
by: B. S. Burlaka
Published: (2021-02-01)

Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner
by: Raphael P. H. Meier, et al.
Published: (2019-03-01)

Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke
by: Kathleen E. Salmeron, et al.
Published: (2019-11-01)

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis
by: Hui Zhang, et al.
Published: (2021-04-01)

Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease
by: Fumihiro Sanada, et al.
Published: (2018-03-01)

Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension
by: Christine B. Bui, et al.
Published: (2019-07-01)

Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
by: Liu Mengyuan, et al.
Published: (2012-09-01)

Tumor-infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model
by: Yu-Ching Fan, et al.
Published: (2020-03-01)

Selection of excipients for the purpose of creating an intranasal gel of interleukin-1 receptor antagonist β (IL-1ra)
by: B. S. Burlaka, et al.
Published: (2020-08-01)

Association between the Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Lymphoma
by: Hosna Sarani, et al.
Published: (2021-04-01)

A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA)
by: Leonardo Oliveira Mendonça, et al.
Published: (2020-08-01)

The Protective Effect of The Interleukin 1 Receptor Antagonist on Chronic Thromboembolic Pulmonary Hypertension Model
by: Serdar Kalemci, et al.
Published: (2019-12-01)

Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1β and IL-1ra production in multiple sclerosis
by: Hans M. Schrijver, et al.
Published: (2003-01-01)

Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia–reperfusion injury
by: Jinzhou Zhu, et al.
Published: (2019-03-01)

Cloning and Expression of Recombinant Human Interleukin 1 Receptor Antagonist in Escherichia Coli Strains, BL21 (DE3), Rosetta (DE3), and Origami (DE3)
by: Hanieh Fardgoli, et al.
Published: (2019-11-01)

Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis
by: Takuro Kobori, et al.
Published: (2018-03-01)

Simvastatin and Recombinant Antagonist of Receptors of Interleukin-1 Modulate Toll-like Receptors in Experimental Acute Ileitis in Rat
by: Aleksandr Zherebiatiev, et al.
Published: (2014-08-01)

Interleukin-1 Receptor Antagonist Reduces Neonatal Lipopolysaccharide-Induced Long-Lasting Neurobehavioral Deficits and Dopaminergic Neuronal Injury in Adult Rats
by: Yi Pang, et al.
Published: (2015-04-01)

Interleukin-6 Induces DEC1, Promotes DEC1 Interaction with RXRα and Suppresses the Expression of PXR, CAR and Their Target Genes
by: Rui Ning, et al.
Published: (2017-11-01)

Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
by: Marco Franzetti, et al.
Published: (2020-08-01)

INCREASING LEVELS OF INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR ANTAGONIST IN BALINESE IDIOPATHIC GRANDMAL EPILEPSY
by: Gelgel Anna-Marita, et al.
Published: (2015-07-01)

Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin
by: Edwin Cuperus, MD, et al.
Published: (2018-03-01)

Interleukin Gene Marker for Febrile Seizures
by: J Gordon Millichap
Published: (2002-07-01)

Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis
by: Hyun Sik Na, et al.
Published: (2020-05-01)

Interleukin‐36α suppresses growth of non‐small cell lung cancer in vitro by reducing angiogenesis
by: Xiaoxiao Xie, et al.
Published: (2021-05-01)

The Therapeutic Role of Interleukin-1 Inhibition in Idiopathic Recurrent Pericarditis: Current Evidence and Future Challenges
by: George Lazaros, et al.
Published: (2017-06-01)

Corrigendum: Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis
by: Hyun Sik Na, et al.
Published: (2020-08-01)

Analysis of the role of the interleukins in colon cancer
by: Xiyi Wei, et al.
Published: (2020-05-01)

The relationship between factor inhibiting HIF-1-alpha (HIF1AN( expression and vascular invasion in colon cancer
by: Reza Najafipour, et al.
Published: (2016-10-01)

Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier
by: Elisabet O. Sjöström, et al.
Published: (2021-10-01)

Accelerated wound healing phenotype in Interleukin 12/23 deficient mice
by: Matias Marie AT, et al.
Published: (2011-12-01)

Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood
by: Rütten, Simon, et al.
Published: (2016)

Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry
by: Marwa Amer, et al.
Published: (2021-10-01)

Mesenchymal Stem Cells Increase Neo-Angiogenesis and Albumin Production in a Liver Tissue-Engineered Engraftment
by: Amedeo Carraro, et al.
Published: (2016-03-01)

Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
by: Toni Hospach, et al.
Published: (2019-07-01)

Cannot write session to /tmp/vufind_sessions/sess_f2666q0dikejco71bbq9n34adm